Oramed Pharmaceuticals

ORMP · NASDAQ

$4.15+$0.09 (+2.22%)TodayMarket closed ·
Prev close $4.06

Who owns ORMP

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 47.1% of ORMP’s shares.

  • Mercer Global Advisors, Inc.9.3%
  • Aquamarine Financial (Cayman) Ltd6.1%
  • Kidron (Nadav)5.9%
  • Gem Investment Advisors, L.L.C.4.9%
  • Next 6 largest institutions20.9%
  • All other shareholders52.9%
Top institutional holders of ORMP
HolderShares% of shares
Mercer Global Advisors, Inc.3.81M9.31%
Aquamarine Financial (Cayman) Ltd2.51M6.14%
Kidron (Nadav)2.41M5.88%
Gem Investment Advisors, L.L.C.2.00M4.88%
Shapiro (Benjamin)1.96M4.79%
SB Capital Management, Inc1.90M4.64%
BlackRock Institutional Trust Company, N.A.1.43M3.50%
Murchinson Ltd.1.29M3.15%
Kidron (Miriam)994.11K2.43%
Hexter Joshua956.14K2.34%

Largest mutual fund holders

Top mutual fund holders of ORMP
HolderShares% of shares
iShares Russell 2000 ETF631.83K1.54%
Fidelity Small Cap Index Fund376.45K0.92%
iShares Russell 2000 Value ETF315.93K0.77%
Vanguard Russell 2000 Index Fund190.62K0.47%
iShares Micro-Cap ETF119.67K0.29%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $1.17M (4 trades) of ORMP on the open market, with no buys.

Latest ORMP insider transactions
InsiderTypeSharesValue
Gabay AvrahamSale20.00K$90.20K
Hexter JoshuaSale30.00K$135.33K
KIDRON NADAVOther107.00K—
KIDRON NADAVOther150.00K—
KIDRON NADAVOther97.00K—
KIDRON NADAVOther49.00K—
KIDRON NADAVOther190.00K—
KIDRON NADAVOther196.50K—
KIDRON NADAVAward368.76K—
KIDRON NADAVAward349.50K—

Short interest

Settled Sep 30, 2026

Shares short
1.43M
Days to cover
7.33
% of shares outstanding
3.50%
Average daily volume
195.60K
Change since last report
+9.6%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.